NavinKumarKapurMD
Cardiology • Baltimore, MDAdult Congenital Heart Disease, Heart Failure & Transplantation, Interventional Cardiology
Physician
Are you Dr. Kapur?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 102 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-5000
Summary
- Dr. Navin Kapur, MD is a cardiologist in Baltimore, Maryland. He is currently licensed to practice medicine in Virginia and Massachusetts. He is affiliated with Tufts Medical Center.
Education & Training
Johns Hopkins UniversityFellowship, Interventional Cardiology, 2006 - 2007- Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2002 - 2005
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1999 - 2002
Georgetown University School of MedicineClass of 1999
Certifications & Licensure
MA State Medical License 2001 - 2025
VA State Medical License 2002 - 2008
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- SHIELD II Clinical Investigation Start of enrollment: 2015 Aug 01
- Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial Start of enrollment: 2019 Dec 12
Publications & Presentations
PubMed
- Comparison of temporary mechanical circulatory support devices for patients with cardiogenic shock after acute myocardial infarction: A network meta-analysis of random...Tetsuya Saito, Atsuyuki Watanabe, Tadao Aikawa, Navin K Kapur, Toshiki Kuno
International Journal of Cardiology. 2025-03-15 - Systemic Circulation in Advanced Heart Failure and Cardiogenic Shock: State-of-the-Art Review.Sara L Hungerford, Kay D Everett, Gaurav Gulati, Kenji Sunagawa, Daniel Burkhoff
Circulation. Heart Failure. 2025-02-01 - Clinical outcomes of the post-closure technique for arteriotomy closure with the Impella cardiac power percutaneous left ventricular assist device.Kevin J John, Haval Chweich, Carey Kimmelstiel, Charles D Resor, Navin K Kapur
The Journal of Invasive Cardiology. 2025-02-01
Authored Content
- RESPONSE: Hybrid Training for Interventional, Heart Failure, and Critical Care MedicineJune 2020
- RESPONSE: Hybrid Training for Interventional, Heart Failure, and Critical Care MedicineJune 2020
- Unloading the Left Ventricle Before Reperfusion in Patients with Anterior ST-Segment Elevation Myocardial Infarction: A Pilot Study Using the Impella CPNovember 2018
Press Mentions
Experts Hash Out Recommendations for Impella CP After DanGer ShockFebruary 14th, 2025- Clinical Outcomes of the Post-Closure Technique for Arteriotomy Closure with the Impella Cardiac Power Percutaneous Left Ventricular Assist DeviceAugust 26th, 2024
- RECOVER IV Impella Trial Halted in the Wake of DanGer ShockJune 18th, 2024
- Join now to see all
Grant Support
- Cardiac Fibrosis Progressive Heart FAILURE: The Role Of EndoglinNational Heart, Lung, And Blood Institute2009–2011
Professional Memberships
- Member
